Our research in oncology is supported through collaborations with groups including The Institute for Cancer Research (ICR), The Northern Institute for Cancer Research at the University of Newcastle (NICR) and Cancer Research UK (CRUK); the National Cancer Institute of the National Institutes of Health in the USA and the Netherlands Cancer Institute (NKI) and more recently with the Peter MacCallum Cancer Centre in Australia.
Our research into diseases of the CNS is supported by a growing network of leading academic research groups, disease charity’s and consortia focused on the research and development of novel treatments for neurodegenerative diseases.
Astex is a member of the Dementia Consortium, a charity-private partnership set up between Alzheimer’s Research UK, MRC Technology and five pharmaceutical companies. The consortium provides drug discovery resources, project management, industry expertise and funding to support collaborative target validation of potential novel drug targets from academia and SMEs (small and medium-sized enterprises).
Dementia Discovery Fund
Astex is a funding partner in the SV Life Science run Dementia Discovery Fund, a venture fund set up to promote innovation in dementia and support the next generation of drug discovery approaches for neurodegenerative disease.